US Stock MarketDetailed Quotes

InspireMD (NSPR)

Watchlist
  • 1.350
  • 0.0000.00%
Close Apr 14 16:00 ET
  • 1.350
  • 0.0000.00%
Post 16:10 ET
63.18MMarket Cap-1.78P/E (TTM)

InspireMD (NSPR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
28.11%8.98M
61.57%3.15M
39.39%2.52M
2.24%1.78M
1.19%1.53M
12.96%7.01M
10.68%1.95M
16.32%1.81M
5.46%1.74M
21.95%1.51M
Operating revenue
28.11%8.98M
61.57%3.15M
39.39%2.52M
2.24%1.78M
1.19%1.53M
12.96%7.01M
10.68%1.95M
16.32%1.81M
5.46%1.74M
21.95%1.51M
Cost of revenue
15.03%6.33M
33.04%1.97M
18.84%1.66M
4.05%1.47M
1.48%1.24M
25.13%5.5M
17.83%1.48M
24.87%1.4M
21.59%1.41M
40.76%1.22M
Gross profit
75.90%2.65M
151.60%1.18M
108.70%864K
-5.44%313K
0.00%292K
-16.66%1.51M
-7.13%469K
-5.48%414K
-32.59%331K
-21.72%292K
Operating expense
49.28%52.26M
34.85%13.26M
56.77%13.92M
55.19%13.33M
52.50%11.75M
52.54%35.01M
55.81%9.84M
46.06%8.88M
47.97%8.59M
62.10%7.71M
Selling and administrative expenses
74.32%37.26M
59.35%9.79M
107.22%10.28M
83.01%9.5M
51.41%7.69M
42.80%21.38M
43.60%6.14M
25.06%4.96M
36.11%5.19M
74.54%5.08M
-Selling and marketing expense
172.75%16.55M
173.58%5.24M
198.37%4.39M
188.72%4.17M
122.31%2.75M
57.02%6.07M
46.29%1.92M
68.04%1.47M
62.00%1.45M
56.98%1.24M
-General and administrative expense
35.29%20.71M
7.62%4.55M
68.76%5.89M
42.22%5.33M
28.59%4.94M
37.84%15.31M
42.40%4.23M
12.88%3.49M
28.21%3.75M
81.06%3.84M
Research and development costs
10.04%15M
-5.90%3.48M
-7.15%3.64M
12.73%3.83M
54.63%4.06M
70.83%13.63M
81.47%3.69M
85.55%3.92M
70.65%3.4M
42.43%2.63M
Operating profit
-48.09%-49.61M
-29.01%-12.08M
-54.23%-13.05M
-57.62%-13.02M
-54.57%-11.46M
-58.46%-33.5M
-61.28%-9.37M
-50.06%-8.46M
-55.41%-8.26M
-69.23%-7.41M
Net non-operating interest income expense
-42.77%891K
53.17%386K
-40.03%343K
-137.61%-132K
-23.04%294K
20.51%1.56M
-46.15%252K
24.08%572K
47.48%351K
205.60%382K
Non-operating interest income
-42.77%891K
53.17%386K
-40.03%343K
----
-23.04%294K
20.51%1.56M
-46.15%252K
24.08%572K
47.48%351K
205.60%382K
Total other finance cost
----
----
----
137.61%132K
----
----
----
----
---351K
----
Other net income (expense)
Income before tax
-52.52%-48.72M
-28.34%-11.7M
-61.06%-12.71M
-66.28%-13.15M
-58.79%-11.17M
-60.93%-31.95M
-70.69%-9.12M
-52.38%-7.89M
-55.78%-7.91M
-65.23%-7.03M
Income tax
6.78%63K
-9.23%59K
Net income
-52.43%-48.79M
-28.20%-11.76M
-61.06%-12.71M
-66.28%-13.15M
-58.79%-11.17M
-60.70%-32.01M
-69.73%-9.17M
-52.38%-7.89M
-55.78%-7.91M
-65.23%-7.03M
Net income continuous Operations
-52.43%-48.79M
-28.20%-11.76M
-61.06%-12.71M
-66.28%-13.15M
-58.79%-11.17M
-60.70%-32.01M
-69.73%-9.17M
-52.38%-7.89M
-55.78%-7.91M
-65.23%-7.03M
Minority interest income
Net income attributable to the parent company
-52.43%-48.79M
-28.20%-11.76M
-61.06%-12.71M
-66.28%-13.15M
-58.79%-11.17M
-60.70%-32.01M
-69.73%-9.17M
-52.38%-7.89M
-55.78%-7.91M
-65.23%-7.03M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-52.43%-48.79M
-28.20%-11.76M
-61.06%-12.71M
-66.28%-13.15M
-58.79%-11.17M
-60.70%-32.01M
-69.73%-9.17M
-52.38%-7.89M
-55.78%-7.91M
-65.23%-7.03M
Basic earnings per share
0.00%-0.76
26.32%-0.14
-6.25%-0.17
-18.18%-0.26
-4.76%-0.22
7.32%-0.76
-46.15%-0.19
-6.67%-0.16
8.33%-0.22
60.38%-0.21
Diluted earnings per share
0.00%-0.76
26.32%-0.14
-6.25%-0.17
-18.18%-0.26
-4.76%-0.22
7.32%-0.76
-46.15%-0.19
-6.67%-0.16
8.33%-0.22
60.38%-0.21
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 28.11%8.98M61.57%3.15M39.39%2.52M2.24%1.78M1.19%1.53M12.96%7.01M10.68%1.95M16.32%1.81M5.46%1.74M21.95%1.51M
Operating revenue 28.11%8.98M61.57%3.15M39.39%2.52M2.24%1.78M1.19%1.53M12.96%7.01M10.68%1.95M16.32%1.81M5.46%1.74M21.95%1.51M
Cost of revenue 15.03%6.33M33.04%1.97M18.84%1.66M4.05%1.47M1.48%1.24M25.13%5.5M17.83%1.48M24.87%1.4M21.59%1.41M40.76%1.22M
Gross profit 75.90%2.65M151.60%1.18M108.70%864K-5.44%313K0.00%292K-16.66%1.51M-7.13%469K-5.48%414K-32.59%331K-21.72%292K
Operating expense 49.28%52.26M34.85%13.26M56.77%13.92M55.19%13.33M52.50%11.75M52.54%35.01M55.81%9.84M46.06%8.88M47.97%8.59M62.10%7.71M
Selling and administrative expenses 74.32%37.26M59.35%9.79M107.22%10.28M83.01%9.5M51.41%7.69M42.80%21.38M43.60%6.14M25.06%4.96M36.11%5.19M74.54%5.08M
-Selling and marketing expense 172.75%16.55M173.58%5.24M198.37%4.39M188.72%4.17M122.31%2.75M57.02%6.07M46.29%1.92M68.04%1.47M62.00%1.45M56.98%1.24M
-General and administrative expense 35.29%20.71M7.62%4.55M68.76%5.89M42.22%5.33M28.59%4.94M37.84%15.31M42.40%4.23M12.88%3.49M28.21%3.75M81.06%3.84M
Research and development costs 10.04%15M-5.90%3.48M-7.15%3.64M12.73%3.83M54.63%4.06M70.83%13.63M81.47%3.69M85.55%3.92M70.65%3.4M42.43%2.63M
Operating profit -48.09%-49.61M-29.01%-12.08M-54.23%-13.05M-57.62%-13.02M-54.57%-11.46M-58.46%-33.5M-61.28%-9.37M-50.06%-8.46M-55.41%-8.26M-69.23%-7.41M
Net non-operating interest income expense -42.77%891K53.17%386K-40.03%343K-137.61%-132K-23.04%294K20.51%1.56M-46.15%252K24.08%572K47.48%351K205.60%382K
Non-operating interest income -42.77%891K53.17%386K-40.03%343K-----23.04%294K20.51%1.56M-46.15%252K24.08%572K47.48%351K205.60%382K
Total other finance cost ------------137.61%132K-------------------351K----
Other net income (expense)
Income before tax -52.52%-48.72M-28.34%-11.7M-61.06%-12.71M-66.28%-13.15M-58.79%-11.17M-60.93%-31.95M-70.69%-9.12M-52.38%-7.89M-55.78%-7.91M-65.23%-7.03M
Income tax 6.78%63K-9.23%59K
Net income -52.43%-48.79M-28.20%-11.76M-61.06%-12.71M-66.28%-13.15M-58.79%-11.17M-60.70%-32.01M-69.73%-9.17M-52.38%-7.89M-55.78%-7.91M-65.23%-7.03M
Net income continuous Operations -52.43%-48.79M-28.20%-11.76M-61.06%-12.71M-66.28%-13.15M-58.79%-11.17M-60.70%-32.01M-69.73%-9.17M-52.38%-7.89M-55.78%-7.91M-65.23%-7.03M
Minority interest income
Net income attributable to the parent company -52.43%-48.79M-28.20%-11.76M-61.06%-12.71M-66.28%-13.15M-58.79%-11.17M-60.70%-32.01M-69.73%-9.17M-52.38%-7.89M-55.78%-7.91M-65.23%-7.03M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -52.43%-48.79M-28.20%-11.76M-61.06%-12.71M-66.28%-13.15M-58.79%-11.17M-60.70%-32.01M-69.73%-9.17M-52.38%-7.89M-55.78%-7.91M-65.23%-7.03M
Basic earnings per share 0.00%-0.7626.32%-0.14-6.25%-0.17-18.18%-0.26-4.76%-0.227.32%-0.76-46.15%-0.19-6.67%-0.168.33%-0.2260.38%-0.21
Diluted earnings per share 0.00%-0.7626.32%-0.14-6.25%-0.17-18.18%-0.26-4.76%-0.227.32%-0.76-46.15%-0.19-6.67%-0.168.33%-0.2260.38%-0.21
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
US President Trump stated in a recent interview that the US war with Iran has 'ended.' According to Axios, Pakistan, Egypt, and Turkey have Show More